Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Classifica tra le azioni #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Prezzo delle azioni
$59.98
Ultima sincronizzazione: 2024-12-13
Capitalizzazione di mercato
$1.22B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Longboard Pharmaceuticals, Inc. (LBPH)

Categoria

Storico del prezzo dell'azione per Longboard Pharmaceuticals, Inc. (LBPH)
Prezzo di chiusura più alto: $59.98 il 2024-12-01

Prezzo di chiusura più basso: $16.35 il 2021-03-01
Storico del prezzo dell'azione di Longboard Pharmaceuticals, Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 1,066.59%
2023 27.45%
2022 -27.54%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH